Related Experiment Video
Updated: May 2, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Inflammatory bowel disease in veterinary medicine
Albert E Jergens1, Kenneth W Simpson
1Department of Veterinary Clinical Sciences, Iowa State University, Ames, Iowa 50010, USA. ajergens@iastate.edu
Canine and feline inflammatory bowel disease (IBD) involves chronic gastrointestinal inflammation. Research suggests genetics and gut bacteria interact, leading to abnormal immune responses and symptoms like vomiting and diarrhea.
Area of Science:
- Veterinary Medicine
- Gastroenterology
- Immunology
Background:
- Inflammatory bowel disease (IBD) in dogs and cats is a complex, immune-mediated gastrointestinal disorder.
- Exact causes are unknown, but genetic factors and gut bacteria likely play a role in disease development.
- Clinical signs include vomiting, diarrhea, and weight loss, with inflammation affecting various GI tract segments.
Purpose of the Study:
- To provide a comprehensive overview of canine and feline IBD.
- To discuss etiopathogenesis, clinical features, diagnosis, and treatment strategies.
- To compare human and canine IBD.
Main Methods:
- Literature review of basic science and clinical studies.
- Analysis of recent advances in molecular tools, disease activity indices, and biomarkers.
- Examination of current treatment recommendations, including dietary, pharmacologic, and microbiota-targeted therapies.
Main Results:
- Objective assessment of IBD severity is now possible with new tools and biomarkers.
- Treatment involves diet, medication, and modulation of the enteric microbiota.
- Comparative analysis with human IBD offers insights into disease mechanisms.
Conclusions:
- Canine and feline IBD are heterogeneous disorders with multifactorial etiologies.
- Integrated approaches combining diagnostics and therapeutics are crucial for managing IBD.
- Further research, including human-canine comparisons, can advance understanding and treatment.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations